Group 1 - The share price of Aquestive Therapeutics, Inc. (NASDAQ: AQST) experienced a significant increase following the announcement from the U.S. Food and Drug Administration (FDA) [1] - Aquestive Therapeutics is focused on advancing medicines to improve patients' lives through innovative science and delivery technologies [1] - The article promotes a weekly newsletter that provides insights into stocks in the biotech, pharma, and healthcare industries, including catalysts and financial forecasts [1]